Riskpilot← Back to searchSign inGet full accessmedQsystem AB
ABActiveOrg 5591713317Karlbergsvägen 74 Lgh 1604Research and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2025
SEK 0
EBITDA margin
—
+11% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
SEK 223K
+1768% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -41K | +11% |
| Net profit | SEK 223K | +1768% |
| Total assets | SEK 10,5M | +0% |
| Equity | SEK 10,4M | +0% |
| Employees | 0 | — |
Legal name
medQsystem AB
Org number
5591713317
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13 september 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska äga och förvalta värdepapper, fast och lös egendom samt bedriva annan med ovan nämnda verksamhet förenlig verksamhet.
Address
Karlbergsvägen 74 Lgh 1604
Email
micael.johansson@nimio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 190 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 | −100 | −8 | −46 | −41 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 1 | −100 | −8 | −46 | −41 |
| Net financials | 7 980 | 3 249 | 81 | 33 | 264 |
| Profit before tax | 7 981 | 3 149 | 73 | −13 | 223 |
| Tax | −2 | — | — | — | — |
| Net profit | 7 979 | 3 149 | 73 | −13 | 223 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 561 | 10 986 | 10 668 | 10 447 | 10 461 |
| Equity | 8 029 | 10 931 | 10 613 | 10 386 | 10 399 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 482 | 5 | 5 | 11 | 12 |
| Total debt | 482 | 5 | 5 | 11 | 12 |
EBITDA margin
-4130400.0%
This company
15.8%
Market median
-26141872% vs market
20212025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
22315400.0%
This company
8.1%
Market median
+275498665% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2019 | |
| Former (2) | ||
| Chairman | 2019 – 2022 | |
| Deputy Board Member | 2019 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of medQsystem AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Micael Johansson | Chief Executive Officer | 0 companies |
| Maria Therese Albinsson | Chairman | 0 companies |
| Magnus Anders Erik Albinsson | Deputy Board Member | 0 companies |
| Nina Inga-Liisa Leikman | Deputy Board Member | 0 companies |